Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults

Determination of respiratory syncytial virus epidemic seasons by using 95% confidence interval of positivity rates, 2011–2021, Germany

(2022) Wei Cai et al.   Influenza and Other Respiratory Viruses

Early initiation of the respiratory syncytial virus season in 2021–2022, Greece

(2022) Styliani Pappa et al.   JOURNAL OF MEDICAL VIROLOGY

Rates of respiratory syncytial virus (RSV)-associated hospitalization among adults with congestive heart failure—United States, 2015–2017

(2022) Stephanie A. Kujawski et al.   PLoS One

Off-season RSV epidemics in Australia after easing of COVID-19 restrictions

(2022) John-Sebastian Eden et al.   Nature Communications

Safety and immunogenicity of a respiratory syncytial virus prefusion F (RSVPreF3) candidate vaccine in older adults: phase I/II randomized clinical trial

(2022) Isabel Leroux-Roels et al.   JOURNAL OF INFECTIOUS DISEASES

Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study

(2022) Beate Schmoele-Thoma et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study

(2021) Jerald Sadoff et al.   JOURNAL OF INFECTIOUS DISEASES

The Interseasonal Resurgence of Respiratory Syncytial Virus in Australian Children Following the Reduction of Coronavirus Disease 2019–Related Public Health Measures

(2021) David A Foley et al.   CLINICAL INFECTIOUS DISEASES

The Future of Respiratory Syncytial Virus Disease Prevention and Treatment

(2021) Joseph B. Domachowske et al.   Infectious Diseases and Therapy

Incidence of Respiratory Syncytial Virus Infection Among Hospitalized Adults, 2017–2020

(2021) Angela R Branche et al.   CLINICAL INFECTIOUS DISEASES

During the COVID‐19 pandemic where has respiratory syncytial virus gone?

(2021) Greta Di Mattia et al.   PEDIATRIC PULMONOLOGY

Delayed Seasonal RSV Surge Observed During the COVID-19 Pandemic

(2021) Rabia Agha et al.   PEDIATRICS

Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic — United States, 2020–2021

(2021) Sonja J. Olsen et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Considerations for a Respiratory Syncytial Virus Vaccine Targeting an Elderly Population

(2021) Laura M. Stephens et al.   Vaccines

Influenza and RSV incidence during COVID-19 pandemic—an observational study from in-hospital point-of-care testing

(2021) Paul Stamm et al.   MEDICAL MICROBIOLOGY AND IMMUNOLOGY

The return of RSV during the COVID‐19 pandemic

(2021) Fernando Ferrero et al.   PEDIATRIC PULMONOLOGY

LB14. Efficacy and Immunogenicity of an Ad26.RSV.preF-based Vaccine in the Prevention of RT-PCR-confirmed RSV-mediated Lower Respiratory Tract Disease in Adults Aged ≥65 Years: A Randomized, Placebo-controlled, Phase 2b Study

(2021) Ann R Falsey et al.   Open Forum Infectious Diseases

Respiratory syncytial virus associated hospitalizations among adults with chronic medical conditions

(2020) Namrata Prasad et al.   CLINICAL INFECTIOUS DISEASES

Global Disease Burden Estimates of Respiratory Syncytial Virus–Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis

(2019) Ting Shi et al.   JOURNAL OF INFECTIOUS DISEASES

Respiratory syncytial virus infection in adults

(2019) Hannah H Nam et al.   BMJ-British Medical Journal

Respiratory Syncytial Virus Seasonality: A Global Overview

(2018) Pablo Obando-Pacheco et al.   JOURNAL OF INFECTIOUS DISEASES

The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates

(2018) Natalie I Mazur et al.   LANCET INFECTIOUS DISEASES

Clinical Features, Severity, and Incidence of RSV Illness During 12 Consecutive Seasons in a Community Cohort of Adults ≥60 Years Old

(2018) Edward A Belongia et al.   Open Forum Infectious Diseases

Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans

(2017) Wivine Burny et al.   Frontiers in Immunology

Epidemiology and clinical characteristics of respiratory syncytial virus infections among children and adults in Mexico

(2016) Ana E. Gamiño-Arroyo et al.   Influenza and Other Respiratory Viruses

Respiratory Syncytial Virus and Other Respiratory Viral Infections in Older Adults With Moderate to Severe Influenza-like Illness

(2014) Ann R. Falsey et al.   JOURNAL OF INFECTIOUS DISEASES

High Morbidity and Mortality in Adults Hospitalized for Respiratory Syncytial Virus Infections

(2013) N. Lee et al.   CLINICAL INFECTIOUS DISEASES

Respiratory Syncytial Virus—A Comprehensive Review

(2013) Andrea T. Borchers et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Risk Factors for Respiratory Syncytial Virus Illness Among Patients with Chronic Obstructive Pulmonary Disease

(2013) Jyotsna Mehta et al.   COPD-Journal of Chronic Obstructive Pulmonary Disease

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

(2013) J. S. McLellan et al.   SCIENCE

Adults 65 Years Old and Older Have Reduced Numbers of Functional Memory T Cells to Respiratory Syncytial Virus Fusion Protein

(2012) Anu Cherukuri et al.   Clinical and Vaccine Immunology

Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries

(2011) H. Quan et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY